These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26809193)

  • 21. Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New Guinea.
    Gare J; Kelly-Hanku A; Ryan CE; David M; Kaima P; Imara U; Lote N; Crowe SM; Hearps AC
    PLoS One; 2015; 10(8):e0134918. PubMed ID: 26244516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression, substance use, viral load, and CD4+ count among patients who continued or left antiretroviral therapy for HIV in St. Petersburg, Russian Federation.
    Pecoraro A; Mimiaga M; O'Cleirigh C; Safren SA; Blokhina E; Verbitskaya E; Yaroslavtseva T; Ustinov A; Lioznov DA; Zvartau E; Krupitsky E; Woody GE
    AIDS Care; 2015; 27(1):86-92. PubMed ID: 25264710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.
    Gezie LD
    BMC Res Notes; 2016 Jul; 9():377. PubMed ID: 27475982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linkage and retention in care and the time to HIV viral suppression and viral rebound - New York City.
    Robertson M; Laraque F; Mavronicolas H; Braunstein S; Torian L
    AIDS Care; 2015; 27(2):260-7. PubMed ID: 25244545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of substance use in adherence to HIV medication and medical appointments.
    Duncan A; VanDevanter N; Ahmed R; Burrell-Piggott T; Furr-Holden CD
    J Assoc Nurses AIDS Care; 2014; 25(3):262-8. PubMed ID: 24503499
    [No Abstract]   [Full Text] [Related]  

  • 26. Distress tolerance and use of antiretroviral therapy among HIV-infected individuals in substance abuse treatment.
    Magidson JF; Seitz-Brown CJ; Listhaus A; Lindberg B; Anderson KE; Daughters SB
    AIDS Patient Care STDS; 2013 Sep; 27(9):518-23. PubMed ID: 23991690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological distress and physical pain appear to have no short-term adverse impact on plasma HIV-1 RNA levels in patients on successful HAART.
    Nettles RE; Keiffer TL; Cofrancesco J; Gallant JE; Quinn T; Jackson B; Flexner C; Carson KA; Wu AW; Siliciano RF
    HIV Clin Trials; 2005; 6(5):262-71. PubMed ID: 16425464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal antiretroviral therapy adherence as evaluated by CASE index score tool is associated with virological suppression in HIV-infected adults in Dakar, Senegal.
    Byabene AK; Fortes-Déguénonvo L; Niang K; Manga MN; Bulabula ANH; Nachega JB; Seydi M
    Trop Med Int Health; 2017 Jun; 22(6):776-782. PubMed ID: 28407436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.
    Lesko CR; Tong W; Moore RD; Lau B
    AIDS Behav; 2017 Apr; 21(4):1016-1024. PubMed ID: 27752872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
    Silveira MP; Maurer P; Guttier MC; Moreira LB
    J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with HIV viral load "blips" and the relationship between self-reported adherence and efavirenz blood levels on blip occurrence: a case-control study.
    Farmer A; Wang X; Ganesan A; Deiss RG; Agan BK; O'Bryan TA; Akers K; Okulicz JF
    AIDS Res Ther; 2016; 13():16. PubMed ID: 27006682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.
    MacDonell K; Naar-King S; Huszti H; Belzer M
    AIDS Behav; 2013 Jan; 17(1):86-93. PubMed ID: 23142855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline Neurocognitive Functioning Predicts Viral Load Suppression at 1-Year Follow-Up Among Newly Diagnosed HIV Infected Patients.
    Shahani L; Salazar L; Woods SP; Hasbun R
    AIDS Behav; 2018 Oct; 22(10):3209-3213. PubMed ID: 29350337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study.
    Mpawa H; Kwekwesa A; Amberbir A; Garone D; Divala OH; Kawalazira G; van Schoor V; Ndindi H; van Oosterhout JJ
    J Int AIDS Soc; 2017 Aug; 20(1):21623. PubMed ID: 28782332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender and mental health aspects of living with HIV disease and its longer-term outcomes for UK heterosexual patients.
    Sherr L; Clucas C; Lampe F; Harding R; Johnson M; Fisher M; Anderson J; Edwards S; Team S
    Women Health; 2012; 52(3):214-33. PubMed ID: 22533897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
    Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
    HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in nutritional, functional and immunological status of HIV-infected adults with antiretroviral therapy.
    Tafese Z; Berhan Y; Abebe H
    Ethiop Med J; 2012 Jan; 50(1):75-87. PubMed ID: 22519164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.